Funding Opportunities

Funding Opportunities

The Ontario Molecular Pathology Research Network (OMPRN) drives new innovations in cancer research by supporting molecular pathology across the province through a number of competitive grants, which encourage multidisciplinary collaboration and mentorship for trainee and early-career pathologists.

OMPRN Grants

GRANT DESCRIPTION AVAILABLE FUNDS DUE DATE
Stream 1 Supports one-year, collaborative research projects that bring together a pathologist Principal Investigator (PI) with a trans-disciplinary Co-Investigator and a pathology trainee. up to $50,000 November 1, 2021
Stream 4 Supports one-year, collaborative research projects based on the applicants’ previous OMPRN-funded research. The proposal must focus on translating research findings from the previous research towards clinical use. Projects will bring together a pathologist Principal Investigator (PI) with a trans-disciplinary Co-Investigator and a pathology trainee. up to $75,000 November 1, 2021

OMPRN Fellowships

FELLOWSHIP DESCRIPTION AVAILABLE FUNDS DUE DATE
Cancer Pathology Research Fellowship (not offered during 2021) Up to two, one year Fellowships are available to support the training of Ontario pathologists for careers in cancer research. Per fellowship: $80,000 for one year, with the potential for an additional $80,000 for consumables. Not offered during 2021.

Other Funding Opportunities

This section contains news on other funding opportunities relevant to Ontario pathology researchers.
Stay up to date on the latest events and funding opportunities with the Network! Sign up for the OMPRN newsletter.

GRANT DESCRIPTION AVAILABLE FUNDS DUE DATE
LLCS-CIHR Clinician Scientist Fellow Award The intent of the Clinician Scientist Fellow Award is to encourage early-stage specialist clinicians to pursue a career in blood cancer research. The award is specifically targeted at MDs near, or recently at, the completion of specialty training in hematology, oncology, hematopathology, pathology, or other related disciplines and who have initiated or have immediate plans to begin supervised research training directed at blood cancers. up to $100,000 per year for 2 years Letter of intent due Dec. 1, 2021.